ES2079323B1 - Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes. - Google Patents

Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.

Info

Publication number
ES2079323B1
ES2079323B1 ES09401346A ES9401346A ES2079323B1 ES 2079323 B1 ES2079323 B1 ES 2079323B1 ES 09401346 A ES09401346 A ES 09401346A ES 9401346 A ES9401346 A ES 9401346A ES 2079323 B1 ES2079323 B1 ES 2079323B1
Authority
ES
Spain
Prior art keywords
igu
group
migraine
derivatives
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09401346A
Other languages
English (en)
Other versions
ES2079323A1 (es
Inventor
Castillo Nieto Juan Carlos Del
Ges Jose Maria Caldero
Acin Juan Roca
Guasch Fernando Gimenez
Rovira Anna Bosch
Barjoan Pedro Dalmasesn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vita Invest SA
Original Assignee
Vita Invest SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest SA filed Critical Vita Invest SA
Priority to ES09401346A priority Critical patent/ES2079323B1/es
Priority to AU26750/95A priority patent/AU2675095A/en
Priority to JP8501679A priority patent/JPH09502205A/ja
Priority to EP95921844A priority patent/EP0714896A1/en
Priority to CA002169050A priority patent/CA2169050A1/en
Priority to PCT/ES1995/000074 priority patent/WO1995035293A1/es
Publication of ES2079323A1 publication Critical patent/ES2079323A1/es
Application granted granted Critical
Publication of ES2079323B1 publication Critical patent/ES2079323B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

DERIVADOS DE INDOL UTILES PARA EL TRATAMIENTO DE LA MIGRAÑA, COMPOSICION Y USO CORRESPONDIENTES. LOS DERIVADOS SON DE FORMULA I DONDE: R1 IGU H, GRUPO ALQUILO O ACILO; R2 IGU , HALOGENO O ALQUILO, HIDROXI, ALCOXI, CIANO, CARBOXAMIDO, CARBOXILO, ALCOXICARBONILO, FENILO, FENILOXI O UN GRUPO -(CH2)N - R6, [N=1-3 Y R6 IGU UN GRUPO CIANO, NITRO, FENILO, CARBOXILO, -CO2R7, -CONR7R8, -S02NR7R8, -COR7, -SO2R7], R7 Y R8 IGU H O UN ALQUILO, R7 Y R8, JUNTO CON EL N PUEDEN FORMAR UN CICLO DE 4-7 ESLABONES; R3, R4 Y R5 IGU H, HALOGENO O UN GRUPO ALQUILO, HIDROXI, ALCOXI, FENILOXI, BENCILOXI O R11R12, [R11R12 IGU H O UN GRUPO, CIANO, NITRO, CARBOXILO, ALCOXICARBONLLO, CARBOXAMIDO O UN GRUPO R3]; A IGU UN GRUPO ALQUILIDENO -(CH2)M- [M IGU 1-5], O ALQUENILO; B *FIG* R9 Y R10 IGU H O UN GRUPO ALQUILO. LOS COMPUESTOS SON UTILES PARA EL TRATAMIENTO DE LA MIGRAÑA.
ES09401346A 1994-06-21 1994-06-21 Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes. Expired - Fee Related ES2079323B1 (es)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ES09401346A ES2079323B1 (es) 1994-06-21 1994-06-21 Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
AU26750/95A AU2675095A (en) 1994-06-21 1995-06-13 Indol derivatives useful for the treatment of migraine, composition and utilization
JP8501679A JPH09502205A (ja) 1994-06-21 1995-06-13 偏頭痛の治療に有用なインドール誘導体、およびそれらの組成物と使用
EP95921844A EP0714896A1 (en) 1994-06-21 1995-06-13 Indol derivatives useful for the treatment of migraine, composition and utilization
CA002169050A CA2169050A1 (en) 1994-06-21 1995-06-13 Indol derivatives useful for the treatment of migraine, composition and utilization
PCT/ES1995/000074 WO1995035293A1 (es) 1994-06-21 1995-06-13 Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09401346A ES2079323B1 (es) 1994-06-21 1994-06-21 Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.

Publications (2)

Publication Number Publication Date
ES2079323A1 ES2079323A1 (es) 1996-01-01
ES2079323B1 true ES2079323B1 (es) 1996-10-16

Family

ID=8286650

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09401346A Expired - Fee Related ES2079323B1 (es) 1994-06-21 1994-06-21 Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.

Country Status (6)

Country Link
EP (1) EP0714896A1 (es)
JP (1) JPH09502205A (es)
AU (1) AU2675095A (es)
CA (1) CA2169050A1 (es)
ES (1) ES2079323B1 (es)
WO (1) WO1995035293A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031488A1 (en) * 1995-04-03 1996-10-10 Sumitomo Pharmaceuticals Company, Limited Novel pyrimidine derivatives efficacious as psychotropic drug and process for the production thereof
DE19613329A1 (de) 1996-04-03 1997-10-09 Hoechst Schering Agrevo Gmbh Substituierte Pyridine/Pyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
ATE303367T1 (de) * 2000-06-13 2005-09-15 5 phenyl substituierte 2-(cyanoamino)-pyrimidine als fungizide
DE10135043A1 (de) * 2001-07-11 2003-01-30 Bayer Cropscience Gmbh Substituierte 3-Heteroaryl(amino- oder oxy)-pyrrolidin-2-one, Verfahren zu deren Herstellung und Verwendung als Herbizide oder als Pflanzenwachstumsregulatoren
HUP0200849A2 (hu) * 2002-03-06 2004-08-30 Sanofi-Synthelabo N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
ATE452130T1 (de) * 2004-10-18 2010-01-15 Lilly Co Eli 1-(hetero)aryl-3-aminopyrrolidinderivate zur verwendung als antagonisten des mglur3-rezeptors
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
WO2008141020A1 (en) * 2007-05-11 2008-11-20 Eli Lilly And Company 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists
MX2010002536A (es) 2007-09-14 2010-08-10 Ortho Mcneil Janssen Pharm 4-fenil-3,4,5,6-tetrahidro-2h, 1'h-[1,4]bipiridinil-2'-onas 1',3'-disubstituidas.
BRPI0918055A2 (pt) 2008-09-02 2015-12-01 Addex Pharmaceuticals Sa derivados de 3-azabiciclo[3,1,0]hexila como moduladores de receptores metabotrópicos de glutamato.
CA2744138C (en) 2008-11-28 2015-08-11 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
ES2409006T3 (es) 2009-05-12 2013-06-24 Janssen Pharmaceuticals Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de los receptores mGluR2
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
SG176021A1 (en) 2009-05-12 2011-12-29 Janssen Pharmaceuticals Inc 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
PL2649069T3 (pl) 2010-11-08 2016-01-29 Janssen Pharmaceuticals Inc Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2
WO2012062759A1 (en) 2010-11-08 2012-05-18 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
US9012448B2 (en) 2010-11-08 2015-04-21 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
SG10201604682VA (en) * 2011-06-10 2016-07-28 Merck Patent Gmbh Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
CN104337812B (zh) 2013-07-29 2018-09-14 广东东阳光药业有限公司 取代的杂芳基化合物及其使用方法和用途
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
PT3096790T (pt) 2014-01-21 2019-10-15 Janssen Pharmaceutica Nv Combinações compreendendo moduladores alostéricos positivos ou agonistas ortostéricos do recetor glutamatérgico metabotrópico do subtipo 2 e seu uso
EA202192105A3 (ru) 2014-02-04 2022-02-28 Янссен Фармацевтика Нв Комбинации, содержащие положительные аллостерические модуляторы или ортостерические агонисты метаботропного глутаматергического рецептора 2 подтипа, и их применение
CN105085491B (zh) * 2014-05-05 2019-06-25 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
WO2016192657A1 (en) * 2015-06-03 2016-12-08 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
CA3077383A1 (en) 2017-09-29 2019-04-04 Sunshine Lake Pharma Co., Ltd. Substituted pyrimidine piperazine compound and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1189064A (en) * 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
GR79215B (es) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
NL8503337A (nl) * 1984-12-04 1986-07-01 Glaxo Group Ltd Indoolderivaten.
CA2043709C (en) * 1990-06-29 2002-01-22 David W. Smith Antimigraine alkoxypyrimidine derivatives
CA2084531A1 (en) * 1991-12-19 1993-06-20 David W. Smith Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines
GB9208161D0 (en) * 1992-04-14 1992-05-27 Pfizer Ltd Indoles

Also Published As

Publication number Publication date
AU2675095A (en) 1996-01-15
CA2169050A1 (en) 1995-12-28
WO1995035293A1 (es) 1995-12-28
ES2079323A1 (es) 1996-01-01
JPH09502205A (ja) 1997-03-04
EP0714896A1 (en) 1996-06-05

Similar Documents

Publication Publication Date Title
ES2079323B1 (es) Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
DK0666858T3 (da) 5-arylindolderivater og deres anvendelse som serotonin(5-HT1)-agonister
DE69823843D1 (de) Benzimidazolinone, benzoxazolinone, benzopiperazinone, indanone und deren derivate als faktor xa inhibitoren
NZ336302A (en) Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
PT885210E (pt) Compostos triciclicos que possuem afinidade de ligacao para receptores de melatonina sua producao e utilizacao
ES2161382T3 (es) Derivados de pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
EA200100428A1 (ru) Производные тетрагидробензазепина, полезные в качестве модуляторов допаминовых d3 рецепторов (антипсихотические агенты)
NZ510097A (en) Pyrroloindoles, pyridoindoles and azepinoindoles useful as 5-HT2C agonists
ATE231149T1 (de) (1,8)-naphthyridinderivate derivate mit antiviraler wirkung
DK0887344T3 (da) Quinoliner og quinazoliner, som er nyttige ved terapi
DE69319614D1 (de) 1,4-benzodiazepinderivate und ihre verwendung als cck-modulatoren
TR199801734T2 (xx) Yeni arilglisinamid t�revleri, �retim y�ntemleri.
TR199901188T1 (xx) Aromatik veya heteroaromatik radikal ile de�i�tirilmi� bifenil t�revleri, ve bunlar� i�eren farmas�tik ve kozmetik bile�imler.
ES2038678T3 (es) Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos.
AR017542A1 (es) Compuestos [indol]naftopiranos, procedimiento para prepararlos, un (co)polimero, un compuesto fotocromatico, una composicion fotocromatica, una matriz(co)polimerica, un articulo solar y un vidriado, todos basados en los compuestos
PT874625E (pt) Derivados de indano para composicoes antipsicoticas
DE59908967D1 (de) Indolinderivate als lichtschutzmittel
BR9801506A (pt) Compostos de quinolina e quinazolina úteis em terapia.
PE20010649A1 (es) Derivados de antranilamida de piperidinas 1,4-di-sustituidas como antagonistas muscarinicos
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
TR200103019T2 (tr) Yeni 8A-ve 9A-15-elemanlı laktamlar
ES2167725T3 (es) Procedimiento para la coloracion de material organico de alto peso molecular, y pigmentos policiclicos.
ATE219775T1 (de) Indolverbindungen, ihre verwendung zum färben und schminken von keratinfasern, sie enthaltende zusammensetzungen und färbeverfanren
PT937708E (pt) Derivados de sulfonamidas
ES2086165T3 (es) Procedimiento para la preparacion de olefinas sustituidas con grupos aromaticos a partir de compuestos cloro-aromaticos.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19940621

Kind code of ref document: B1

Effective date: 19940621

FD1A Patent lapsed

Effective date: 20000201